Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: Incidence, risk factors and outcomes

Bone Marrow Transplantation

Volumn 34, Issue 7, 2004, Pages 615-619

  Hidalgo, J D ^a   Krone, R ^a   Rich, M W ^a   Blum, K ^a   Adkins, D ^a   Fan, M Y ^a   Brown, R ^a   Devine, S ^a   Graubert, T ^a   Blum, W ^a   Tomasson, M ^a   Goodnough, L T ^a   Vij, R ^a   DiPersio, J ^a   Khoury, H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac toxicity; Hematopoietic stem cell transplantation; Outcomes; Tachyarrhythmia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DIGOXIN; DILTIAZEM; ETOPOSIDE; HYPERTENSIVE FACTOR; MELPHALAN; RITUXIMAB;

ADULT; AGE; AGED; ARTICLE; CANDIDIASIS; CARDIOVERSION; CASE CONTROL STUDY; COLITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEBRILE NEUTROPENIA; FEMALE; GRAM NEGATIVE INFECTION; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

EID: 5044245043     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704623     Document Type: Article

References (15)

1. Nicolini B, Rovelli A, Uderzo C. Cardiotoxicity in children after bone marrow transplantation. Pediatr Hematol Oncol 2000; 17: 203-209.
2. Braverman AC, Antin JH, Plappert MT et al. Cyclophosphamide cardiotoxicity: a prospective evaluation of new dosing regimens. J Clin Oncol 1991; 9: 1215-1223.
3. Shan K, Lincoff AM, Young J. Anthracycline-induced cardiotoxicity. Ann Intern Med 1996; 125: 47-58.
4. Alidina A, Lawrence D, Ford LA et al. Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with female sex and cardiac risk factors. Biol Blood Marrow Tranplant 1999; 5: 322-327.
5. Alessandrino EP, Bernasconi P, Caldera D et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999; 23: 533-537.
6. Omotoso O, Khoury H, Brown R et al. Outcomes of stem cell transplant recipients requiring mechanical ventilation and cared for in the Bone marrow Transplant Unit. Blood 2001; 98: 350b.
7. Rubenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplant: a case for evidence-based guidelines. Ann Intern Med 1996; 125: 625-633.
8. Diaz de Heredia C, Moreno A, Olive T et al. Role of the intensive care unit in children undergoing bone marrow transplantation with life-threatening complications. Bone Marrow Transplant 1999; 24: 163-168.
9. Jackson SR, Tweeddale MG, Barnett MJ et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998; 21: 697-704.
10. Olivieri A, Corvatta L, Montanari M et al. Paroxysmal atrial fibrillation after high-dose melphalan in five patients auto-transplanted with blood progenitor cells. Bone Marrow Transplant 1998; 21: 1049-1053.
11. Cazin B, Gorin NC, Laporte JP et al. Cardiac complication after bone marrow transplantation. A report on a series of 63 consecutive patients. Cancer 1986; 57: 2061-2069.
12. Kupari M, Volin L, Suokas A et al. Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. Bone Marrow Transplant 1990; 5: 91-98.
13. Murdych T, Weisdorf DJ. Serious cardiac complication during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant 2001; 28: 283-287.
14. Van Besien K, Tabocoff J, Rodriguez M et al. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable and complete remissions, but a high rate of regimen related toxicity. Bone Marrow Transplant 1995; 15: 549-555.
15. Brockstein BE, Smiley C, Al-Sadir J et al. Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors. Bone Marrow Transplant 2000; 25: 885-894.